MATAspire Web-app for Drug Addiction
(MATAspire Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The MATAspire intervention is a web-app designed to promote substance misuse prevention education and bolster protective coping skills whereby students complete six weekly interactive modules using a smart device or computer. Each module is approximately 15-20 minutes long and focuses on select substances and coping strategies: (i) adaptive coping strategies, (ii) alcohol, (iii) cannabis, (iv) nicotine, (v) prescription drugs and opioids, (vi) final module. The modules are based on key theoretical constructs, behavior change strategies, and practical module components: attitudes (knowledge), perceived susceptibility (risk perceptions), and subjective norms (normative re-education). The intervention will be evaluated via a time series design using a sample of (\~1000 students) randomly assigned to either the intervention or the control conditions at a public institution in Southern California.
Are You a Good Fit for This Trial?
This trial is for current Cal State Northridge students who are 18 or older and have an active CSUN email address.Inclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- MATAspire Web-app
Trial Overview
The study tests a web-app called MATAspire, which provides six weekly interactive modules to help prevent substance misuse and teach healthy coping skills. Students are randomly assigned to use the app or be in a control group.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Web-app with 6 weekly coping \& substance modules
No access to web-app
Find a Clinic Near You
Who Is Running the Clinical Trial?
California State University, Northridge
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.